Table 6. Differentiation of Patients... | American Society of Hematology

Table 6.

Differentiation of Patients With MM From Patients With MGUS or Osteoporosis

Parameter	MM			MGUS (n = 40)	Osteoporosis (n = 40)
	Stage I and II (n = 23)	Stage III (n = 27)	All Stages (n = 50)
h-PYD
≤50 μmol/mol	59%	12%	33%	87%^6-151	85%^6-151
>50 μmol/mol	41%^6-150	88%^6-150	67%^6-150	13%	15%
h-DPD
≤15 μmol/mol	64%	22%	40%	97%^6-151	85%^6-151
>15 μmol/mol	46%^6-150	78%^6-150	60%^6-150	3%	15%
i-DPD
≤8 μmol/mol	52%	7%	28%	95%^6-151	62%^6-151
>8 μmol/mol	48%^6-150	93%^6-150	72%^6-150	5%	38%

Parameter	MM			MGUS (n = 40)	Osteoporosis (n = 40)
	Stage I and II (n = 23)	Stage III (n = 27)	All Stages (n = 50)
h-PYD
≤50 μmol/mol	59%	12%	33%	87%^6-151	85%^6-151
>50 μmol/mol	41%^6-150	88%^6-150	67%^6-150	13%	15%
h-DPD
≤15 μmol/mol	64%	22%	40%	97%^6-151	85%^6-151
>15 μmol/mol	46%^6-150	78%^6-150	60%^6-150	3%	15%
i-DPD
≤8 μmol/mol	52%	7%	28%	95%^6-151	62%^6-151
>8 μmol/mol	48%^6-150	93%^6-150	72%^6-150	5%	38%

Cutoff levels for the individual markers refer to the upper limit of their 95% confidence interval determined in the collective of healthy controls.

Sensitivity.

Specificity.